Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:paracetamol
gptkb:codeine |
| gptkbp:alternativeName |
paracetamol/codeine combination
|
| gptkbp:availableOn |
gptkb:tablet
capsule effervescent tablet |
| gptkbp:brand |
Kapake
Solpadeine Tylex Zamol |
| gptkbp:broadcastOn |
controlled drug (UK, higher strengths)
|
| gptkbp:cause |
vomiting
dizziness headache itching skin rash withdrawal symptoms |
| gptkbp:compatibleWith |
long-term use
United States (as co-codamol) |
| gptkbp:contains |
non-opioid analgesic (paracetamol)
opioid (codeine) |
| gptkbp:contraindication |
allergy to paracetamol
allergy to codeine |
| gptkbp:form |
oral
|
| https://www.w3.org/2000/01/rdf-schema#label |
Co-codamol
|
| gptkbp:legalStatus |
over-the-counter (UK, lower strengths)
prescription only (UK, higher strengths) |
| gptkbp:liverMetabolism |
yes
|
| gptkbp:marketedIn |
gptkb:Ireland
gptkb:United_Kingdom |
| gptkbp:maximumDailyDose |
8 tablets (standard strength)
|
| gptkbp:notRecommendedFor |
children under 12
people with severe liver disease |
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:prescribes |
severe pain
moderate pain |
| gptkbp:renalMetabolism |
yes
|
| gptkbp:riskFactor |
overdose
dependence liver damage (overdose) respiratory depression (overdose) |
| gptkbp:sideEffect |
addiction
nausea constipation drowsiness |
| gptkbp:usedFor |
pain relief
|
| gptkbp:bfsParent |
gptkb:Codeine
|
| gptkbp:bfsLayer |
6
|